SIREN : 440198687
CENEXI is a French company founded 24 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in FONTENAY-SOUS-BOIS (94120), this company of category GE shows in 2024 a revenue of 92.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92 852 450 € | 79 473 576 € | 80 124 293 € | 85 280 530 € | 89 858 581 € | 89 338 984 € | 87 264 165 € | 89 917 044 € | 94 349 644 € |
| Net income | -20 120 192 € | -20 893 651 € | -10 355 893 € | -7 222 601 € | -9 478 885 € | -8 899 335 € | -5 677 533 € | -4 664 178 € | 1 657 355 € |
| EBITDA | -8 440 069 € | -12 330 908 € | -4 778 673 € | -2 296 667 € | -8 215 764 € | -3 326 225 € | -287 445 € | -1 543 719 € | 4 490 968 € |
| Net margin | -21.7% | -26.3% | -12.9% | -8.5% | -10.5% | -10.0% | -6.5% | -5.2% | 1.8% |
In 2024, CENEXI achieves revenue of 92.9 M€. Activity remains stable over the period (CAGR: -0.2%). Vs 2023, growth of +17% (79.5 M€ -> 92.9 M€). After deducting consumption (23.0 M€), gross margin stands at 69.8 M€, i.e. a rate of 75%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -8.4 M€, representing -9.1% of revenue. Positive scissor effect: EBITDA margin improves by +6.4 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -20.1 M€ (-21.7% of revenue), which will impact equity.
92 852 450 €
69 843 251 €
-8 440 069 €
-14 493 107 €
-20 120 192 €
-9.0%
The debt ratio (= Financial debt / Equity x 100) stands at -2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -37%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
-1.9%
-36.811%
-14.83%
-0.05
24.4%
In 2024, the debt ratio of CENEXI (-1.90) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of CENEXI (-36.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
In 2024, the repayment capacity of CENEXI (-0.05) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 34.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
34.45
-58.132
In 2024, the liquidity ratio of CENEXI (34.45) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of CENEXI (-58.1x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 14 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 160 days. Excellent situation: suppliers finance 146 days of the operating cycle (retail model). Inventory turnover is 106 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. WCR is negative (-218 days): operations structurally generate cash. Notable WCR improvement over the period (-290%), freeing up cash.
-56 256 514 €
14 j
160 j
106 j
-218 j
Compare CENEXI with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of CENEXI in 2024 is 92.9 M€.
CENEXI recorded a net loss in 2024.
The headquarters of CENEXI is located in FONTENAY-SOUS-BOIS (94120), in the department Val-de-Marne.
The tax return of CENEXI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CENEXI operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.